Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05176899 · ClinicalTrials.gov registry record
Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting
A clinical trial, sponsored by Eko Devices.
- Terminated
- Registry status
- 103
- Enrollment target
NCT05176899: Clinical Trial study, sponsored by Eko Devices.
NCT05176899 is a clinical trial that was terminated before completion, run by Eko Devices. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05176899 was terminated before completion, sponsored by Eko Devices.
- TERMINATED
- Registry status
- 103 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the impact of Eko AI plus EMAS (Eko Murmur Analysis Software) on a clinician's referral decision in a real-world primary care setting. There is an additional objective of understanding patient outcomes when patients are referred for cardiology follow-up and/or echocardiogram.
Primary Outcome
Echocardiogram order rates before and after SENSORA implementation, for individual providers and aggregated for the site as a whole
Interventions
- DEVICE Use of Eko CORE electronic stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-03-11 |
| Est. Completion | 2024-01-18 |
Why NCT05176899 stopped before completion
NCT05176899 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko CORE electronic stethoscope is the first listed.
NCT05176899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05176899 about?
NCT05176899 is a clinical study titled "Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting". The purpose of this research is to evaluate the impact of Eko AI plus EMAS (Eko Murmur Analysis Software) on a clinician's referral decision in a real-world primary care setting. There is an additional objective of understanding patient outcomes when patients are referred for cardiology follow-up an...
What is the current status of trial NCT05176899?
This trial is currently terminated. The enrollment target is 103 participants. The study started on 2022-03-11. Estimated completion is 2024-01-18.
What interventions are being tested in trial NCT05176899?
The interventions under investigation include: Use of Eko CORE electronic stethoscope (DEVICE).
Who is sponsoring clinical trial NCT05176899?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI